CRKN — Crown Electrokinetics. Income Statement
0.000.00%
Last trade - 00:00
- $2.63m
- $2.00m
- $0.15m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.505 | 0.1 | 0 | 0 | 0.153 |
Cost of Revenue | |||||
Gross Profit | -0.109 | -0.52 | 0 | — | -0.733 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.12 | 8.19 | 33.6 | 15.1 | 21.8 |
Operating Profit | -2.61 | -8.09 | -33.6 | -15.1 | -21.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.3 | -9.6 | -40.8 | -14.3 | -29 |
Net Income After Taxes | -4.3 | -9.6 | -40.8 | -14.3 | -29 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.3 | -9.6 | -40.8 | -14.3 | -29 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.3 | -9.6 | -40.8 | -14.4 | -29.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -45 | -62.2 | -180 | -49.4 | -4.91 |
Dividends per Share |